SCHEMBL845405

SCHEMBL845405

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cnccn3)cc2)cc1)[C@@H]1CCCN1C(=O)c1cnccn1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.46
DGAT1 O75907 5/20 0.45
KMT2A Q03164 2/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
NPC1 O15118 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845048 0.87 DGAT1 (0.50) DGAT1RHOCRHOANPC1SMN1; SMN2
SCHEMBL13272258 0.86 TRPV1 (0.38) TRPV1DGAT1KMT2ARHOCRHOA
SCHEMBL845297 0.84 RHOC (0.48) TRPV1RHOCRHOANPC1SMN1; SMN2
SCHEMBL844934 0.83 RHOC (0.51) TRPV1KMT2ARHOCRHOANPC1
SCHEMBL844963 0.83 DGAT1 (0.47) DGAT1NPC1SMN1; SMN2KDM4ECYP2C9
SCHEMBL845570 0.82 TP53BP1 (0.45) RHOCRHOARXFP1KDM4ECYP2C9
SCHEMBL845725 0.82 RHOC (0.45) DGAT1RHOCRHOANPC1CYP2C9
SCHEMBL845070 0.81 TRPV1 (0.44) TRPV1RHOCRHOANPC1KDM4E
SCHEMBL845338 0.80 RHOC (0.48) KMT2ARHOCRHOANPC1CYP2C9
SCHEMBL873200 0.79 RHOC (0.48) KMT2ARHOCRHOANPC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed